Clinical Trial Update: Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST [NA]

View source ↗

Summary

Clinical trial investigating the combination of radiotherapy with Ripretinib for unresectable advanced gastrointestinal stromal tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumors

Drugs mentioned

• QINLOCK (ripretinib)

Snippet

Sponsor: First Affiliated Hospital of Chongqing Medical University | Conditions: Gastrointestinal Stromal Tumors | NA | Status: RECRUITING